During development, neural precursors migrate in response to positional cues such as growth factor gradients. However, the mechanisms that enable precursors to sense and respond to such gradients are poorly understood. Here we show that cerebellar granule cell precursors (GCPs) migrate along a gradient of brain-derived neurotrophic factor (BDNF), and we demonstrate that vesicle trafficking is critical for this chemotactic process. Activation of TrkB, the BDNF receptor, stimulates GCPs to secrete BDNF, thereby amplifying the ambient gradient. The BDNF gradient stimulates endocytosis of TrkB and associated signaling molecules, causing asymmetric accumulation of signaling endosomes at the subcellular location where BDNF concentration is maximal. Thus, regulated BDNF exocytosis and TrkB endocytosis enable precursors to polarize and migrate in a directed fashion along a shallow BDNF gradient.
INTRODUCTION
Chemotaxis is an oriented cell migration wherein a cell becomes polarized with a defined front and back, enabling the cell to move in a forward direction toward an attractive agent (Ridley et al., 2003; Vicente-Manzanares et al., 2005; Webb et al., 2005) . Genetic and mechanistic studies have identified many of the molecules required for the complex interactions among substrate, membrane, and cytoskeleton that allow movement (Affolter and Weijer, 2005; Dujardin et al., 2003; Fishell and Hatten, 1991; Myers et al., 2005; Nagano et al., 2002 Nagano et al., , 2004 Qin et al., 2000; Snapper et al., 2005) . However, the mechanisms that lead to polarization and directional migration in response to extracellular cues are not well understood.
Chemotaxis is critical for neural development, as neural precursors travel long distances from proliferative zones to reach correct positions for mature function. At particular stages in development, precursors travel in predictable directions and along defined axes. While early precursors migrate tangentially along a rostral-caudal or circumferential path, both cerebral and cerebellar precursors migrate radially at defined developmental stages. Neurons of the cerebral cortex travel outward from the ventricular zone to the cortical layers, while cerebellar granule cell precursors (GCPs) travel radially inward from a proliferative zone in the external granule cell layer (EGL) and traverse the molecular layer to reach the internal granule cell layer (IGL) (Hatten, 1999 (Hatten, , 2002 Komuro and Yacubova, 2003; Komuro et al., 2001; . During radial migration, precursors often migrate along glial ''tracks'' that restrict migration decisions to a simple range of choices: cells can remain stationary, move forward, or move backward (Nadarajah et al., 2001; Rakic, 1971; Rivas and Hatten, 1995) . Precursors move relatively slowly during radial migration, so migration of GCPs from the EGL to the IGL occurs over the course of several days in vivo (Bellion et al., 2005; Edmondson and Hatten, 1987; Fishell and Hatten, 1991; Komuro et al., 2001; . Once GCPs reach the IGL, migration ceases. Together these attributes make it possible to examine the mechanisms that regulate radial migration of GCPs in vitro, in vivo, or in organotypic cultures.
Cytoskeletal changes required for radial migration include remodeling of the microtubule network that surrounds the nucleus and extends forward to a centrosome. In addition, changes of the actin cytoskeleton and associated myosin motors enable the leading process to move forward and the trailing process to retract as the cell migrates. These cytoskeletal changes are regulated by intracellular molecular components that orchestrate cell polarity (Bielas and Gleeson, 2004; Hatten, 2002; Tsai and Gleeson, 2005) .
In order for cells to move in the appropriate direction in vivo, extracellular cues must regulate these polarity molecules. Among the possible attractive cues are neurotrophins (Borghesani et al., 2002; Jones et al., 1994; Polleux et al., 2002; Yamauchi et al., 2003; Yoshizawa et al., 2005) , chemokines ), netrins (Bloch-Gallego et al., 1999; Hamasaki et al., 2001; Yee et al., 1999) , semaphorins (Bagnard et al., 2001; Gammill et al., 2006; Kerjan et al., 2005) , and ephrins (Conover et al., 2000; Lu et al., 2001; Santiago and Erickson, 2002) , while possible repulsive cues include slit (Brose and Tessier-Lavigne, 2000; Kramer et al., 2001; Piper and Little, 2003; Wu et al., 1999) and netrins (Hamasaki et al., 2001 ). Brain-derived neurotrophic factor (BDNF) is an extracellular factor that regulates neural precursor migration. In vivo, neural migration is abnormal in the cerebral and cerebellar cortex of mutant mice that lack or overexpress BDNF, and BDNF can stimulate migration of precursors in tissue culture system (Borghesani et al., 2002; Jones et al., 1994; Polleux et al., 2002; Ringstedt et al., 1998) . However, it is not known whether this ligand is involved in movement per se or in the directionality of the response. Here we show that a gradient of BDNF exists in the developing cerebellum and this gradient both orients and stimulates migration of GCPs. Correct orientation of migration depends on TrkB-dependent secretion of BDNF by GCPs and subsequent accumulation of activated TrkB receptors in endosomes located in or adjacent to the leading process. We identify Tiam1/Rac and PI (3, 4, 5) P3 (PIP3) phospholipids as critical components in the chemotactic response to BDNF and demonstrate that these components colocalize with TrkB in signaling endosomes at the leading process. Thus, TrkB-regulated BDNF release and localized endocytosis of BDNF/TrkB constitute mechanisms that enable GCPs to establish an intracellular gradient of signaling components steeper than the shallow extracellular BDNF gradient so that GCPs migrate directionally.
RESULTS

BDNF Promotes Radial Migration of Granule Cell Precursors
In bdnf À/À mice migration of GCPs from the EGL to IGL is impaired (Borghesani et al., 2002 ). An extracellular factor such as BDNF might stimulate migration with or without providing a directional cue. As an in vivo gradient is needed for a factor to provide a directional cue, we investigated the distribution of BDNF protein in the developing cerebellum. We examined BDNF concentrations in lysates of EGL and IGL microdissected at postnatal day 7 (P7), when GCPs are actively migrating. As shown in Figure S1A in the Supplemental Data (available with this article online), BDNF concentration is 2-fold higher in IGL than in EGL. Taken together with previous studies of BDNF expression using in situ hybridization and immunostaining (Borghesani et al., 2002; Rocamora et al., 1993; Wetmore et al., 1990) , these results indicate that regulated expression of BDNF in vivo generates a gradient that increases along the migratory path from the EGL to the IGL. To investigate the role of BDNF as a chemotactic factor for neural precursors, we established an in vitro real-time migration assay ( Figure S1B ) wherein GCPs from P6 mice are exposed to an exogenous BDNF gradient and observed by time-lapse microscopy. As shown in Figure S1B , BDNF loaded into the agarose plug diffuses into the medium, creating a gradient of BDNF as validated by ELISA ( Figure S1C ). Using this system, we traced the migratory paths of individual GCPs during 2 hr of data acquisition under control conditions, when exposed to a BDNF gradient, or when exposed to a uniform distribution of BDNF. For each condition, we superimposed the paths of each GCP from four experiments on a common origin to generate the composites in Figure 1A . While both uniform BDNF and a BDNF gradient increased the percentage of cells that migrate compared with control, the gradient had a greater effect ( Figure 1B) . Furthermore, cells migrate in a random direction in control or uniform BDNF condition, but preferentially migrate toward the BDNF source in the gradient condition ( Figure 1C and Movie S1 in the Supplemental Data). Thus, BDNF promotes migration most effectively when presented as a gradient, and it provides a directional cue for movement.
Mathematical modeling of chemotactic responses indicates that basal migration can be modeled by a random walk; chemotactic responses can be modeled as a biased random walk with high coefficient of nonrandomness (m) (Shreiber et al., 2003) . As shown in Figure 1D , the BDNF gradient significantly increased m compared with control or uniform BDNF conditions, without significantly altering other attributes of migration, such as velocity or duration ( Figure S2 ). Thus, BDNF functions as a chemotactic factor, converting the stationary state or random walk of precursors under basal conditions into a directed random walk that is oriented toward the BDNF source.
BDNF Activation and Redistribution of TrkB
Mediates Directional Migration BDNF has two receptors, TrkB and p75NTR, both of which are expressed by GCPs and could be involved in BDNFinduced chemotaxis (Carter et al., 2003; Klein et al., 1990; Segal et al., 1995) . To distinguish the receptor pathway or pathways required for BDNF-induced migration of GCPs, we used both pharmacologic and genetic approaches. We find that K252a, an agent that prevents Trk kinase activity (Tapley et al., 1992) , markedly inhibits directed migration of GCPs ( Figure 1E ). Treatment with K252a not only reduces the percentage of migratory cells, but also reduces directional movement of GCPs toward the BDNF source ( Figure 1F ). K252a also prevents GCP migration in an organotypic slice culture ( Figure 1G ), demonstrating that this Trk inhibitor can prevent migration in response to endogenous neurotrophin. We validated that K252a, at the dose used, prevents BDNF-induced activation of TrkB and its downstream signaling components (Figure 1E) . Because GCPs express p75NTR as well as TrkB, and p75NTR is implicated in Schwann cell migration (Bentley and Lee, 2000) , we tested migration of GCPs from p75NTR exon III mutant mice (Lee et al., 1992) . BDNF increased both migration and directed movement of p75 mutant cells ( Figure 1H ). Taken together with previous in vivo analyses of various TrkB (Medina et al., 2004; Minichiello and Klein, 1996) and p75NTR (Carter et al., 2003) mutants, these data demonstrate that TrkB, but not p75NTR, mediates BDNF-induced chemotaxis of GCPs. A chemotactic response requires polarization of the intracellular cytoskeleton, resulting in elongation of a leading process directed up the gradient. The leading process features prominent actin filaments. As shown in Figure 2A , in response to BDNF stimulation GCPs extend a leading process toward the source of BDNF; this leading process contains abundant actin filaments that can be visualized with fluorescent phalloidin. TrkB receptors are localized in the leading process ( Figures 2A5-2A8 ) and oriented toward the BDNF source ( Figure 2B ). Moreover, TrkB receptors concentrated in the leading process are activated receptors and can be visualized using anti-phospho-Trk (anti-pY490) ( Figure 2C ). These results indicate that TrkB is activated and relocalized in response to a BDNF gradient. Other receptors expressed by GCPs do not accumulate in the leading process, as shown by immunostaining with antibodies to CXCR4 (data not shown), a chemokine receptor expressed by GCPs Lu et al., 2001 ).
We find that TrkB also relocalizes in response to uniform BDNF stimulation. However, under these conditions, the probability that TrkB will accumulate at the side of the cell facing the agarose plug is equal to the probability that TrkB will accumulate at the opposite side of the cell (in control and uniform conditions, the agarose plug is loaded with vehicle) ( Figure 2B ). This is in striking contrast to localization of TrkB in response to a gradient, where TrkB is more than twice as likely to accumulate at the side of the cell facing the agarose plug that is the source of BDNF rather than at the opposite side of the cell. These data indicate that polarized localization of TrkB receptors to the site of maximal BDNF concentration may be an important component that determines the directionality of the chemotactic response.
The migration assay used here enables us to distinguish a directed migratory response from a generalized increase in motility, and so is appropriate for studies of BDNF-induced chemotaxis. However, GCPs extend a relatively short leading process when migrating along a laminin substrate instead of a radial glial fiber. To determine whether Bergmann glia and GCPs were cocultured for 1 day, treated with 10 ng/ml BDNF for 1 hr, and stained with anti-TrkB (red). 3D reconstruction is shown. Broken line represents glia fiber. Arrow indicates GCP soma (green), and arrowheads show polarized TrkB receptors at the front of soma (left) and in the GCP leading process (right). Scale bar, 5 mm. (E) Schematic of TrkB polarization in GCPs migrating along glia fiber in (D). (F) Internalized TrkB receptors localize in early endosomes. GCPs were exposed to gradient BDNF for 12 hr and stained with anti-a-adaptin (red) and anti-TrkB (green). Arrow indicates polarized GCPs. BDNF source is at the top. Scale bar, 5 mm.
TrkB is also localized to the more elaborated leading processes of GCPs migrating along glial fibers, we examined TrkB distribution in GCP-Bergmann glia cocultures stimulated with BDNF. As shown, TrkB (red) is seen at the front of the GCP soma (green) and also in the leading process of this migrating cell ( Figures 2D and 2E ). Thus, when GCPs are migrating on a laminin substrate or along a Bergmann glial fiber, TrkB receptors localize to the leading processes of GCPs moving in response to BDNF stimulation. Furthermore, in the presence of a BDNF gradient, TrkB receptors preferentially localize to the cellular site where BDNF is at a maximal concentration.
TrkB receptors in the leading processes of stimulated GCPs have a punctate distribution and appear to be inside the limits of the plasma membrane. Therefore, we asked whether these puncta represent endosomes, using an antibody against a-adaptin, an endocytic component enriched in early endosomes (Gonzalez-Gaitan and Jackle, 1997; Takei and Haucke, 2001) . As shown, internalized TrkB receptors colocalize with a-adaptin and other early endosomal markers after BDNF stimulation ( Figure 2F ), indicating that these receptors are located in an endosomal compartment. To determine whether redistribution of TrkB to endosomes in the leading process also occurs in vivo, and therefore might orchestrate radial migration during development, we examined the localization of TrkB in GCPs as they migrate from the inner EGL toward the IGL. Our results reveal that TrkB receptors are enriched in punctate structures within a crescent or extended process at the front of GCPs ( Figures 3A1-3A4 ). The identity of these cells as GCPs was verified by the expression of Zic, a marker of the granule cell lineage (Aruga et al., 1994) ( Figure 3A ). To determine whether localization of TrkB receptors to the leading process in vivo requires a BDNF gradient, we investigated TrkB localization in bdnf À/À mice. In contrast to the polarized localization of TrkB puncta seen in wild-type animals, TrkB immunostaining in bdnf À/À mice exhibits a random distribution pattern ( Figures 3A5-3A8 , 3C, and 3D), similar to that seen in unstimulated GCPs in vitro ( Figure 2A ). While TrkB clusters in GCPs are directed toward the IGL in wild-type mice, TrkB clusters in GCPs of bdnf À/À mice are more often directed toward or parallel to the pia, and thus point in the wrong direction for radial migration. Consistent with our studies in vitro, TrkB receptors in the leading processes of wildtype GCPs in vivo are predominantly in endosomes that can be immunostained with antibodies to a-adaptin (Figures 3B1-3B4) (65% and 54% of TrkB pixels colocalize with a-adaptin in wild-type and bdnf À/À mice, respectively; n = 5, p < 0.05); thus, polarization of TrkB signaling endosomes in vivo depends on a BDNF gradient. Together these data indicate that a chemotactic response to BDNF involves relocalization of activated TrkB receptors to endosomes at the cellular site where BDNF is maximal, and these endosomes mark the direction of movement.
TrkB Endocytosis Is Required for Directed Cell Migration
The data above suggest that trafficking of vesicular TrkB receptors might coordinate directed migration of GCPs. While receptor endocytosis was previously viewed as Staining is with anti-TrkB (red) and anti-zic (green). (A4) and (A8) a mechanism for receptor downregulation and degradation (Di Fiore and De Camilli, 2001 ), accumulating evidence indicates that intracellular trafficking of signaling endosomes can be important in executing ligand-initiated responses (Ginty and Segal, 2002) . This is particularly true for Trk receptors, which remain activated for prolonged periods of time following stimulation (Ginty and Segal, 2002) . To address the timing and extent of receptor endocytosis in GCPs, we used a biochemical approach in which we analyze surface receptors by biotinylation. The proportion of TrkB located at the cell surface of GCPs declines with increased time of BDNF stimulation ( Figures 4A  and 4B ). The time course of internalization is fairly slow, and there is a lag between internalization and degradation of receptor ( Figures 4B and 4C ).
To determine whether this slow endocytosis of TrkB receptors might be required for directed migration, we used monodansyl cadaverine (MDC), a pharmacologic agent that inhibits internalization of surface membrane molecules (Heerssen et al., 2004) . Treatment of GCPs with MDC prevents BDNF-induced TrkB receptor endocytosis ( Figure 4E ), while there is no effect on TrkB signaling ( Figure 4D ). We find that MDC significantly reduces the percentage of cells that migrate in response to a BDNF gradient ( Figure 4E ). Analysis of paths taken by motile cells revealed that MDC treatment abrogates directionality of GCP migration ( Figure 4F ). In contrast, MDC actually increases the percentage of cells that migrate in the absence of BDNF ( Figure 4F ), indicating that this treatment does not interfere with mechanics of movement. The inhibitory effect of MDC on directed migration of GCPs was recapitulated in organotypic slice culture ( Figures  4G-4I ), indicating that endocytosis is required for migration of GCPs stimulated by endogenous BDNF. These data suggest that endocytosis of TrkB receptors is required for a chemotactic response to BDNF.
We next used a molecular approach to verify that endocytosis of Trk receptors is needed for GCP migration. We used a dominant-negative form of dynamin (K44A), which interferes with clathrin-dependent and clathrin-independent endocytosis (Damke et al., 1994; Robinson, 1994; van der Bliek et al., 1993) . Previous studies indicate that dynamin is needed for endocytosis of Trk receptors and other membrane proteins (Grimes et al., 1996; Damke et al., 1994; Zhang et al., 2000) . When we infect organotypic cerebellar slices with lentivirus expressing dynamin K44A and GFP, most GFP-positive GCPs are unable to migrate out of the EGL, and remain there 3 days later ( Figure 4K ). In contrast, when cultures are infected with lentivirus expressing wild-type dynamin and GFP, virtually all the GFP-positive GCPs migrate out of the EGL within 3 days (Figures 4J and 4L) . Thus, expression of dominantnegative dynamin K44A, like treatment with MDC, markedly inhibits migration of GCPs in slice cultures responding to endogenous neurotrophins. Together these findings indicate that endocytosis of TrkB receptors is critical for BDNF-stimulated cell polarization and chemotaxis.
BDNF Functions as an Autocrine Ligand to Amplify a Local Gradient
In previous studies we found that migration of GCPs out of the EGL is impaired in bdnf À/À mice in vivo, and that GCPs of these animals exhibit decreased migration in tissue culture assays (Borghesani et al., 2002) . As shown in Figure 5A , both gradient and uniform BDNF increase migration of bdnf À/À GCPs. However, in contrast to results observed with wild-type cells, uniform BDNF stimulates migration of mutant GCPs to the same extent as a BDNF gradient. Furthermore, unlike wild-type cells, GCPs of bdnf À/À mice migrate randomly in response to a BDNF gradient ( Figures 5B and 5C ). Thus, an exogenous BDNF gradient stimulates migration of mutant cells, but the cells cannot recognize or respond to the gradient in a directionally appropriate manner.
These findings provide us with a system that dissociates BDNF-induced motility from BDNF-induced directionality, and so can be used to determine the mechanisms whereby a cell polarizes correctly with a leading process at the location of maximal BDNF concentration. To ascertain whether polarized accumulation of TrkB in the leading process is needed to orient migration up the BDNF gradient, we visualized TrkB-containing signaling endosomes in GCPs of bdnf À/À mice. As shown in Figures 5D and 5E , TrkB does redistribute to endosomes that accumulate at one side of the mutant cells in response to a BDNF gradient. However, in bdnf À/À GCPs, the location where signaling endosomes accumulate is random relative to the BDNF gradient (Figure 5D ). These studies suggest that bdnf À/À GCPs migrate randomly in vitro because signaling endosomes are not correctly polarized. From these results taken together, we conclude that a BDNF gradient induces polarized accumulation of signaling endosomes in leading processes of wildtype GCPs both in vivo and in vitro, and that the location of the signaling endosomes dictates direction of migration. The specific deficit in chemotaxis of bdnf À/À cells could reflect a cell-autonomous requirement for BDNF for initiation of directed migration. Alternatively, precursors obtained from bdnf À/À mice might acquire additional deficits that preclude a chemotactic response. To distinguish these possibilities, we asked whether acute reduction in BDNF recapitulates the mutant phenotype. Using lentivirus to express siRNA for BDNF, we reduced the level of BDNF protein in GCPs by 80% ( Figure 6A ). As shown in Figures 6B and 6C , GCPs expressing bdnf RNAi exhibited impaired chemotaxis in response to a BDNF gradient. In contrast, GCPs treated in parallel with a control virus remained capable of directed chemotaxis. The data with acute BDNF knockdown are similar to the results obtained using GCPs from bdnf À/À mice (compare Figure 6B and Figure 5A , and Figure 6D and Figure 5C ). Thus, BDNF expression and secretion by GCPs are required for a chemotactic response to an exogenous ligand gradient. These findings suggest the intriguing possibility that autocrine BDNF might amplify the BDNF gradient and so enhance directed migration. Previous studies have shown that neurotrophins themselves can induce neurotrophin secretion (Canossa et al., 1997) . We therefore asked whether exposing GCPs to a BDNF gradient might induce BDNF release and thereby amplify the local gradient. To address this question, we stimulated GCPs with Neurotrophin 4 (NT4). While NT4 stimulates TrkB activation, endocytosis, and signaling (Yuen and Mobley, 1999) , the ligand is antigenically distinct from BDNF, and so we can monitor BDNF release in response to NT4. As shown in Figure 6E , stimulation of GCPs with NT4 causes BDNF secretion. Based on the timing and amount of BDNF released (approximately 1.2 3 10 À7 femptomole/cell released within 6 hr), stimulated secretion of BDNF could amplify the local concentration gradient and so facilitate a chemotactic response. Given that BDNF is released by GCPs in response to TrkB activation, we asked whether BDNF functions in an autocrine manner to stimulate directed migration of GCPs. To do so we analyzed migration of GCPs in organotypic slice cultures following infection with lentivirus expressing bdnf siRNA together with GFP. We monitored migration by pulse-labeling GCPs with BrdU, then allowing 36 hr for BrdU-positive cells to migrate from the EGL to the IGL. As shown in Figures 6F and 6G , GFP-positive GCPs expressing bdnf siRNA exhibit reduced migration compared with GCPs infected with a control virus. However, migration of the surrounding noninfected GCPs is not affected by the bdnf siRNA construct. Thus, BDNF is required in a cell-autonomous fashion for GCP chemotaxis in slice cultures. Together these data suggest a model wherein the perceived intracellular gradient is amplified in two ways: first, by BDNF-stimulated BDNF release, and second, by localized accumulation of BDNF/TrkB-containing signaling endosomes at the site where BDNF concentration is maximal.
PI3 Kinase and Tiam1/Rac Mediate BDNF-Induced Chemotaxis
To determine the mechanism by which localized, endocytosed TrkB receptors orchestrate directed migration of GCPs, we asked which of the signaling pathways activated by TrkB are required for directed migration. In nonneural systems both phosphatidylinositol kinase (PI3K) and mitogen-activated protein kinase (MAPK) have been implicated in chemotaxis, and these pathways are activated by TrkB (Funamoto et al., 2002; Huang et al., 2004; Huang and Reichardt, 2003) . Pretreatment of cerebellar GCPs with LY294002, a PI3K inhibitor, blocks BDNF-induced GCP migration and the directional bias induced by a BDNF gradient (Figures 7A and 7B ). This brief treatment selectively interferes with PI3K signaling in GCPs (Figure 7C ) but does not interfere with basal migration or affect survival. Thus, the PI3K pathway has a critical role in both the increased motility and directional response induced by a BDNF gradient.
In contrast, pretreatment of GCPs with U0126, an inhibitor of the extracellular signal-regulated kinase (Erk) pathway, does not alter BDNF-induced initiation or directionality of migration ( Figure S3 ). While previous studies indicated that both PI3K and MAPK contribute to chemotaxis in response to nerve growth factor (NGF) or other factors (Huang et al., 2004; Iijima et al., 2002; Sawada et al., 2000) , only the PI3 kinase pathway is essential for BDNFinduced migration of GCPs. The products of PI3 kinases, PIP3 phospholipids, serve as intermediaries that localize and stimulate Rho-family G-proteins, and might thereby promote cell motility (Affolter and Weijer, 2005; Bokoch et al., 1996; Hawkins et al., 1995) . To determine whether PI3 kinase promotes BDNF-induced GCP migration by stimulating Rho-family G-proteins, we asked whether these proteins are involved in BDNF-induced chemotaxis. Toxin B, which inhibits diverse Rho-family GTPases, prevents BDNF-induced migration ( Figure 8A ). We next asked which family members are activated in GCPs by BDNF. We find that BDNF induces activation of endogenous Rac and cdc42 in GCPs and that activation of Rac is abrogated by Toxin B (Figures 8B-8E ). We did not detect activation of Rho in response to BDNF (data not shown). These data suggest that BDNF-induced activation of Rac, cdc42, or both is critical for GCP chemotaxis.
During chemotaxis, PIP3 and Rac often activate one another and thereby amplify a subcellular gradient. Surprisingly, in GCPs BDNF-induced Rac activation does not depend on PIP3 phospholipids; inhibition of PI3 kinase using LY294002 has no effect on Rac activation ( Figure 8F ). Activated Rac itself can stimulate PI3 kinase activity under some circumstances (Keely et al., 1997; Tolias et al., 1995; Zheng et al., 1994) ; however, inhibition of BDNF-induced Rac/cdc42 by Toxin B does not prevent PI3 kinase activation ( Figure 8G ). Thus, BDNF-induced migration requires two independent pathways, one involving Rac/cdc42 and one involving PI3 kinase. Although these pathways are not dependent on one another, both are downstream of TrkB, as pretreatment of GCPs with K252a abolishes BDNF-induced activation of Rac ( Figure 8H ) and PI3 kinase (Figure 7C) . Taken together, these results demonstrate that activation and internalization of TrkB receptors, as well as PI3 kinase and Rac activation, are essential for BDNF-induced directed migration.
Since Rac activation is not initiated by PIP3 phospholipids in this system, we asked how TrkB stimulates Rac activity. In the developing cerebellum, a Rac-specific guanine nucleotide exchange factor (GEF), Tiam1, is highly expressed in GCPs (Ehler et al., 1997) . While Tiam1 is often activated by lipid products of PI3 kinase (Mertens et al., 2003; Sander et al., 1998) , Tiam1 can also be recruited to a signaling complex in a PI3 kinase-independent manner (Lambert et al., 2002) . Consistent with recent studies (Miyamoto et al., 2006) , we find that in GCPs, endogenous TrkB coprecipitates with endogenous Tiam1 in a BDNFstimulated manner ( Figure 9A ), suggesting that this might be a pathway for activation of Rac by TrkB receptors. To determine whether this pathway is required for directed migration, we used a lentivirus siRNA to reduce expression of Tiam1 ( Figure 9B ). Tiam1 siRNA, but not control lentivirus, inhibits BDNF-induced Rac activation ( Figures 9B and  9C ). Lentivirus expressing Tiam1 siRNA also blocks BDNFinduced directional migration of GCPs in our real-time migration assay and organotypic cultures (Figures 9D-9G) . Collectively, these results indicate that BDNF activation of TrkB stimulates two parallel pathways, Tiam1/Rac and PI3 kinase, and that both pathways are needed for chemotaxis. We asked whether Tiam1 and phospholipids colocalize with TrkB-containing signaling endosomes. Following BDNF gradient stimulation, PIP3 phospholipids and Tiam1 colocalize with TrkB in endosomes in the leading process ( Figures 10A and 10B) , suggesting that these two pathways are spatially coordinated.
Large signaling complexes containing TrkB and downstream signaling molecules also form in vivo. As shown, Tiam1 colocalizes with TrkB in GCPs of wild-type mice ( Figure 10C ), and this complex is seen in the leading processes of the cells located at the innermost portion of the EGL. TrkB colocalizes with Tiam1 in wild-type mice (67% of TrkB pixels colocalize with Tiam1 in wild-type mice, while 50% colocalize in bdnf À/À mice; n = 6, p < 0.001), indicating that signaling endosomes containing both TrkB and Tiam1 are selectively localized to the side of the cell with a maximal concentration of BDNF. Thus, both in vitro and in vivo, TrkB and associated signaling molecules localize to endosomes at the cellular site facing the BDNF source. Collectively, these data indicate that endocytosis and localization of complex signaling endosomes to the front of neural precursors are critical elements of the neurotrophin-induced chemotactic response.
DISCUSSION
During development, neural precursors of the cerebral and cerebellar cortex migrate radially from a proliferative zone, traverse the developing cortex, and then cease migrating once they reach their final destinations (Hatten, 1999; . Cues that simultaneously increase migration and provide directionality are optimal for regulating this behavior. We find that this is exactly the effect of BDNF. Our results demonstrate that a BDNF gradient not only stimulates motility, but also determines direction of migration. While other soluble factors and cell-cell interactions undoubtedly contribute to GCP migration and so limit the severity of the migration defect in bdnf À/À mice (Kerjan et al., 2005; Klein et al., 2001; Komuro and Rakic, 1993; Lu et al., 2001; Rio et al., 1997; Zhu et al., 2002) , our data indicate that BDNF functions as a chemotactic factor both in vivo and in vitro.
A major question in chemotaxis is how cells perceive a subtle gradient and become correctly polarized. We calculate that the difference in BDNF concentration between the front and the back of the granule cell soma is approximately 6% of the BDNF concentration in vivo, or approximately 0.1 to 0.3 femptomolar in both our in vivo and in vitro systems. We have identified two mechanisms whereby GCPs amplify the perceived gradient. One simple mechanism for amplifying a gradient is to augment the local concentration of ligand. Consistent with previous studies in other cell types (Saarelainen et al., 2001; Yang et al., 2006) , we find that activation of TrkB receptors stimulates release of BDNF from wild-type GCPs. This regulated release of ligand cannot occur in GCPs that lack BDNF due to germline mutations or acute expression of bdnf siRNA. As a result, GCPs that lack BDNF are unable to chemotax properly in response to a BDNF gradient. The timing and extent of BDNF release in response to TrkB activation suggest that regulated release could play a role in GCP chemotaxis toward BDNF. If BDNF released by each cell, approximately 1.2 3 10 À7 femptomole, spreads through a volume of 5 ml, the steepness of the gradient would increase by 8%. This increase would significantly affect the gradient itself and hence migration. The protein CAPS2, which promotes secretion of BDNF (Sadakata et al., 2004) , may be a critical component of this autocrine release. Indeed, a recent study demonstrated that mice lacking CAPS2 exhibit impaired GCP migration (Sadakata et al., 2007) . A second mechanism that amplifies the gradient is localized accumulation of TrkB-containing signaling endosomes at the side of the cell where BDNF concentration is maximal. Signaling endosomes containing activated TrkB receptors accumulate at the leading processes of wild-type GCPs that are poised to begin migrating from the EGL. This localized accumulation is not observed in mice that lack BDNF. To determine whether localized accumulation of TrkB-containing signaling endosomes is required for directed migration, we used both a dissociated cell migration assay and organotypic cultures. Pharmacologic interventions that prevent endocytosis of TrkB receptors inhibit BDNF-induced chemotaxis in dissociated cultures. In contrast, these pharmacologic interventions do not inhibit basal migration of GCPs, indicating that endocytosis is required for the chemotactic response to BDNF rather than mechanics of motility. Similarly, both pharmacologic and genetic inhibitors of Trk endocytosis interrupt migration of GCPs in slice cultures wherein GCPs respond to endogenous chemotactic cues. These findings reveal a crucial role of TrkB receptor endocytosis in the chemotactic response to BDNF.
Although endocytosis has long been regarded as a mechanism of receptor signal attenuation, it is becoming appreciated that the function of endocytosis is not limited to signal downregulation and receptor removal (Le Roy and Wrana, 2005) . In neuronal cells receptor endocytosis is involved in long-distance signaling (Ginty and Segal, 2002) and is needed to redistribute signaling molecules during cell fate determination (Hutterer and Knoblich, 2005; Kramer, 2000; Le Borgne, 2006) . In yeast, endocytosis and plasma membrane recycling contribute to cell polarization (Valdez-Taubas and Pelham, 2003) . Vesicle endocytosis and trafficking may also play a role in migration (Rosse et al., 2006; Sheen et al., 2004) . In mammary carcinoma cells, an epidermal growth factor (EGF) gradient causes accumulation of endocytosed EGF receptors on the side of the cell facing the EGF source. In migrating neural precursors, vesicles accumulate in the leading process (Schaar and McConnell, 2005) . Genetic studies in Drosophila indicate that mutation of the ubiquitin-ligase D-cbl leads to impaired migration of oocyte border cells. This mutation attenuates EGF-receptor ubiquitination and so alters receptor endocytosis and signaling (Jekely et al., 2005) . We now show that BDNF-induced initiation and directionality of migration are both abrogated by endocytosis inhibitors, but these agents do not affect GCP migration in the absence of BDNF. Thus, endocytosis of TrkB receptors is needed for BDNF-induced chemotaxis.
Our data indicate that correct localization and formation of TrkB-containing signaling endosomes are required for BDNF-induced chemotaxis. Vesicles containing TrkB preferentially accumulate at the front of wild-type GCPs stimulated to chemotax by a gradient of BDNF. In contrast, when wild-type GCPs are stimulated with uniformly distributed BDNF, TrkB-containing vesicles are oriented in any direction, and cells migrate with arbitrary directionality. Strikingly, in GCPs prepared from bdnf À/À mice and stimulated either by a BDNF gradient or by a uniformly distributed BDNF, TrkB-containing vesicles are also oriented in multiple directions. In this genetic model, arbitrary localization of receptors is associated with random direction of migration. We conclude that both formation and localization of signaling endosomes are important for correct cell polarization and directional migration of GCPs in response to a BDNF gradient, and that this provides a second mechanism for amplifying the chemotactic gradient. PI3 kinase activation and Tiam1-mediated activation of Rac are also critical components of the migratory response to BDNF. Localization of activated TrkB, PIP3 phospholipids, and Tiam1 to signaling endosomes ensures that the cytoskeletal changes mediated by Rac and phospholipids are coordinated so that both designate the same directionality. As proposed in the local coupling model for chemotaxis (Arrieumerlou and Meyer, 2005) , we suggest that these cytoskeletal rearrangements cumulatively differentiate the front from the back of the cell. Because activated TrkB receptors and downstream molecules are in signaling endosomes directed toward the source of the gradient, the cell reliably moves forward toward the BDNF source. In vivo, this ensures directed movement of GCPs from the EGL toward the IGL.
Together, the findings here suggest the following model for BDNF regulation of directed migration of GCPs. As GCPs mature, expression of BDNF increases (Maisonpierre et al., 1990) . Therefore mature granule cells in the IGL produce BDNF that disperses through the cerebellar cortex, forming an extracellular gradient from the IGL toward the EGL. This BDNF gradient stimulates TrkB receptors of GCPs that are poised to migrate. In turn, activated TrkB receptors of these precursors initiate autocrine release of BDNF, amplifying the ligand gradient and also causing further TrkB activation and endocytosis. Localized endocytosis of activated TrkB results in accumulation of signaling endosomes at the cellular location where BDNF is maximal, polarizing the cell through the actions of Rac and PIP3 phospholipids. Thus, autocrine release of BDNF and localized accumulation of signaling endosomes amplify the chemotactic gradient and correctly polarize the cell for directed migration.
EXPERIMENTAL PROCEDURES
See Supplemental Data for detailed procedures.
Lentiviral Infection
Dissociated GCPs from P4 mice were resuspended in virus-containing N2 medium with 0.4 mg/ml poly-brene (Sigma), plated at high density (2-4 3 10 6 cell/ml) in an uncoated 6-well tissue culture plate overnight, and then changed to N2 medium with 2 mg/ml Shh. After 48 hr, aggregate cultures were dissociated with papain, and then used for biochemical or cell biological assays. Infection efficiency of GCPs with lentivirus averaged 80%.
Activation of Rac1, cdc42, and RhoA, and TrkB Internalization TrkB internalization was evaluated by biotinylation of surface TrkB with EZ-Link Sulfo-NHS-biotin (Pierce). Rac1, RhoA, and cdc42 activation were assessed by GST-PBD and GST-RBD pull-down assay kit (UBI). See Supplemental Data.
Real-Time Migration Assay
GCPs were prepared and plated. Four hours later a gradient of BDNF was created by loading two micrograms BDNF to fifty microliters agarose gel at one side of a tissue culture dish ( Figure 1B ). Cells were incubated for 4 hr at 37 C to allow diffusion of BDNF and were observed under an inverted microscope in bright field. A field close to the agarose was selected for observation and pictures were taken every 2 min for 2 hr (at 4-6 hr). We measured (1) percentage of cells that migrate, (2) speed of migration, and (3) direction of migration, either toward or away from the BDNF source.
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/55/1/53/DC1/.
